Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 178 active Chronic Lymphocytic Leukemia trials
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Study Type: Interventional Phase 2
A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Study Type: Interventional Phase 1
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
Study Type: Interventional Phase 2
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Study Type: Interventional Phase 2
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome
Study Type: Interventional Phase 1
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
Study Type: Interventional
ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL
Study Type: Interventional Phase 1
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 2
There are 178 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now